Real World Evidence for Oritavancin Use in Gram-Positive Infections
Media is any form of research output that is recorded and played. This is most commonly video, but can be audio or 3D representations.
Article full text
These articles are part of a supplement to Drugs – Real World Outcomes titled “Real World Evidence for Oritavancin Use in Gram-Positive Infections” wholly funded by Melinta Therapeutics. You can find the supplement here.
The above summary slides represent the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full texts online (see “read the peer-reviewed publication” opposite).
© The authors, CC-BY-NC 2020.